Delivery Order SPE2DB20D1109-SPE2DB23FP54Q

Award Date 7/17/23
Potential Completion Date 7/18/23
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $12,444.76 and runs through March 21, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and is valued at $2,230.72. The contract is a Firm Fixed Price Delivery Order with a completion date of June 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds...
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $19,994.13 and an ultimate completion date of April 25, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price pricing type, and there is no set-aside designation indicated....
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a firm fixed price of $2,465.48. The award is a delivery order that is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $22,383.03 and has an ultimate completion date of July 1, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
The federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S to the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $17,944.81 and is a firm fixed-price delivery order. The contract is not designated under any set-aside program. Amerisourcebergen Drug Corp holds a larger Indefinite...
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, to the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The total ceiling value of the delivery order is $9,677.86. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 16, 2024. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $21,977.50 and an ultimate completion date of December 17, 2024. The contract is not designated as a set-aside. In...
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,985.78 and is a Firm Fixed Price Delivery Order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside and does not appear to be associated with a larger contracting vehicle. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., under a Firm Fixed Price delivery order. The contract has a ceiling value of $63,258.20 and an ultimate completion date of December 8, 2023. The contract was not set aside for any specific business type....
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB23FP54Q
    Delivery Order

This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $21,019.96 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. No subcontractors were mentioned in the provided information.

Generated 2/27/25, 10:44 AM